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Introduction {#sec1}
============

HIV-associated neurocognitive disorders (HAND) are a chronic, progressing spectrum of diseases that lead to a range of neurologic disorders, including HIV-associated dementia. The major pathologic manifestation that persists in HAND patients with antiretroviral treatment (ART) is synaptodendritic damage and the accumulation of microglia, the resident immune cell of the central nervous system (CNS); however, the mechanisms underlying synaptic damage remain elusive. Synapse loss is associated with infiltration of macrophages from outside of the CNS and activation of microglia. Both HIV-infected macrophage populations can release cytokines, viral proteins, and excitotoxins, which can lead to synaptic damage ([@bib32]) and are potential reservoirs for the virus ([@bib3]). Although patients on ART experience milder forms of HAND, they still experience chronic inflammation ([@bib21]). Infected microglia and uninfected, but active microglia may be working in tandem to slowly release proinflammatory cytokines and reactive oxygen species that, over time, can lead to synaptodendritic damage ([@bib37], [@bib40]). Additional aspects of inflammatory responses have been implicated in HAND, including the unfolded protein response (UPR) and its resultant activation of EIF2 ([@bib2], [@bib18], [@bib23]).

Although the major pathological manifestation of HAND is synaptodendritic damage, the response during initial exposure to HIV and ART is unknown largely because current models for HIV-mediated neuroinflammation are limited by species differences and human tropism of the virus. For instance, the HIV-1 Tat transgenic mouse model exhibits neuroinflammation and behavioral deficits, but it only expresses a single viral protein from astrocytes ([@bib20]). In addition, while isolated microglia from human patients can provide important insights, this is only a snapshot of the end stage of the disease. Therefore, the development of an *in vitro* human system allowing the interaction of the main cell types involved in HAND is needed to further understand the neuropathogenesis and develop novel therapeutics.

We have developed a human-induced pluripotent stem cell (hiPSC)-based model. Whereby, we separately differentiate hiPSCs into forebrain-like excitatory neurons, astrocytes, and microglia, and then combine them to create a tri-culture, with or without HIV infection of the microglia and with or without ART. Our protocol rapidly produces microglia-like cells (iMg) that express multiple classical markers in mono-culture, productively infect with HIV, and respond to ART. In addition, we have developed a differentiation protocol for functional astrocyte-like cells (iAst) that express hallmark proteins. Utilizing this system, we investigated the effects of HIV infection (Inf), infection with the antiretroviral efavirenz (EFZ) (Inf + EFZ), and EFZ treatment alone (Uninf + EFZ), compared to uninfected tri-cultures (Uninf) and to each other. Interestingly, acute HIV infection reduced synaptophagy by both infected iMg and uninfected iMg in the cultures. Inf also caused gene expression changes consistent with activated inflammatory cytokine signaling in iMg and activation of EIF2 signaling in iMg, iAst, and iPSC-derived neurons (iNrn). Although Inf + EFZ reduced many inflammatory markers, EIF2 signaling activation persisted in the iNrn, and RhoGDI and CD40 signaling persisted in the iMg. In addition, EFZ treatment alone invoked its own discrete inflammatory response, reaffirming the toxic effects of EFZ ([@bib6]) and revealing pathways that may contribute to the toxicity. Our system, which recapitulates key findings in patient studies, provides a platform to mechanistically understand responses to HIV seen in human studies and further reveal the complex roles of the individual cell types during infection ± ART, how ART alone can elicit an inflammatory response, and the prominent role microglia play in the early inflammation response to HIV infection in the brain.

Results {#sec2}
=======

iMicroglia Exhibit Similar Gene and Protein Expression as Other iPSC-Derived Microglia {#sec2.1}
--------------------------------------------------------------------------------------

To develop a tractable system for studying HAND *in vitro*, we adapted two previously published protocols to generate iMg from four separate iPSC lines ([Figure 1](#fig1){ref-type="fig"}A). First, iPSCs are differentiated into CD41+ CD235+ common myeloid progenitors (CMPs) through a 9-day process ([@bib29]). Next, using a modified 11-day protocol ([@bib1]) CMPs are differentiated into a highly pure population of ramified iMg that express CX3CR1, IBA1, TMEM119, and P2RY12 ([Figures 1](#fig1){ref-type="fig"}B, 1C, and [S1](#mmc1){ref-type="supplementary-material"}A). Based on the Abud protocol, we used the small molecules interleukin-34 (IL-34) and colony-stimulating factor 1 (CSF-1), as these are the ligands for CSF1R and are necessary for microglia development *in vivo* ([@bib12]), and transforming growth factor β1 (TGF-β1), as it helps induce an *in vivo* pattern of gene expression ([@bib15]). Fetal bovine serum was implemented to increase viability. iMg exhibited a 179-, 28-, and 11-fold increase in *CX3CR1* (p \< 0.0001), *P2RY12* (p \< 0.05), and *TMEM119* (p \< 0.01), respectively, over monocyte-derived macrophages (MDMs) by qRT-PCR ([Figures 1](#fig1){ref-type="fig"}D--1F). Microglial identity was further confirmed by RNA sequencing (RNA-seq) ([Figures 1](#fig1){ref-type="fig"}G and [S1](#mmc1){ref-type="supplementary-material"}B). Importantly, iMg also express CCR5 ([Figure S1](#mmc1){ref-type="supplementary-material"}C), one of the co-receptors necessary for HIV infection ([@bib11]). iMg also lacked expression of myeloid progenitor markers ([Figure S1](#mmc1){ref-type="supplementary-material"}F). Finally, we compared our iMg with human MDMs as well as datasets from primary human adult and fetal microglia, iPSCs, induced hematopoietic progenitor cells, and iMicroglia from Abud and colleagues ([@bib1]). Principal-component analysis revealed closer clustering of our iMg (pink) to primary human microglia (blue) than previously published iPSC-derived microglia (light orange) ([Figure 1](#fig1){ref-type="fig"}H).Figure 1Generation and Characterization of iMg(A) Timeline for iMg differentiation.(B) Immunostaining for microglia specific markers: CX3CR1, TMEM119, IBA1, and P2RY12, secondary and IgG controls. All cultures were stained for DAPI. Scale bar represents 50 μm.(C) Percentage of DAPI(+) cells that are double-positive for microglia marker. n = 3 cell lines, error bars represent SEM.(D--F) qRT-PCR validation for expression of *CX3CR1* (D), *P2RY12* (E), and *TMEM119* (F) in iMg. Probes normalized to *GAPDH* expression. n = 3 cell lines, one-way ANOVA, Dunnett\'s post hoc analysis, ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗∗^p \< 0.0001; error bars represent SEM.(G) Bulk RNA-seq normalized read counts of specific microglia markers from iMg and MDMs. n = 4 iMg lines, n = 3 MDMs. Benjamini-Hochberg, false discovery rate (FDR) = 0.01, ^∗∗^p \< 0.01, ^∗∗∗∗^p \< 0.0001; error bars represent SEM.(H) Principal-component analysis (PCA) for monocyte-derived macrophages, iMicroglia, and ([@bib1]) iMg, iPSC, iHPC, and primary human microglia. Each dot represents a bulk RNA-seq sample. MDM, monocyte-derived macrophage; iHPC, induced hematopoietic progenitor cells. iPSC, iHPC, Hum. Mg., and iMg samples were all retrieved from [@bib1].

iMg Are Productively Infected with HIV and Respond to Multiple Antiretrovirals {#sec2.2}
------------------------------------------------------------------------------

To establish the effect of HIV infection and ART on microglia, we infected iMg mono-culture with 50 ng/mL of the CSF-derived, R5-tropic JAGO strain of HIV ([@bib4]). After a 15-day infection, a time point based on previous studies of MDMs ([@bib28]), 94.5% ± 5.5% of the iMg were positive for the HIV capsid protein P24 and exhibited vast multinucleation ([Figures 2](#fig2){ref-type="fig"}A and 2B). Most (89.1% ± 3.8%) P24(+) iMg were multinucleated ([Figure 2](#fig2){ref-type="fig"}C), while no P24(−) iMg were multinucleated ([Figure 2](#fig2){ref-type="fig"}D), showing that multinucleation is exclusively associated with infection. Reverse transcriptase activity showed peak viral production occurred near day 15 ([Figure 2](#fig2){ref-type="fig"}E).Figure 2HIV-Infected iMicroglia Produce an Inflammatory Response, and Respond to EFZ(A) Immunostaining showing reduced percentage of P24+ (red) IBA1+ (green) iMg in HIV-infected mono-cultures + EFZ treatment compared with infected cultures with no EFZ treatment. Scale bar represents 50 μm.(B) Percentage of P24+ cells in mono-culture iMg at D15 for infected and Inf + EFZ conditions. n = 4 infections from 3 cell lines, error bars represent SEM.(C) Percent of P24+ single nucleated and multinucleated iMg in mono-culture for infected and Inf + EFZ conditions. n = 4 infections from 3 cell lines.(D) Percent of P24(−) single nucleated and multinucleated iMg in mono-culture for Inf and Inf + EFZ conditions. n = 4 infections from 3 cell lines.(E) Reverse transcriptase activity of Uninf, Inf, and Inf + EFZ (20 nM) iMg show productive infection and response to EFZ. n = 3 independent infections of WT6, one-way ANOVA, Dunnett\'s post hoc analysis; ^∗^p \< 0.05, ^∗∗∗∗^p \< 0.0001; error bars represent SEM.(F--I) Cytokine analysis of infected iMg mono-culture displays increase in IL-1b (F), IL-8 (G), TNF-α (H), and IL-1a (I) production in the infected iMg. n = 3 independent infections of WT6, one-way ANOVA, Dunnett\'s post hoc analysis; ^∗^p \< 0.05, ^∗∗^p \< 0.01; error bars represent SEM.

We initially infected iMg from iPSCs of four individuals. Remarkably, the iMg of one individual showed limited infection ([Figure S1](#mmc1){ref-type="supplementary-material"}E). Subsequent genotyping revealed heterozygosity for the CCR5Δ32 mutation, known to reduce infectivity by HIV ([@bib24]) ([Figure S1](#mmc1){ref-type="supplementary-material"}D). This line was thus excluded from subsequent studies, but this example demonstrates the validity of our system to model known regulators of human infection.

To determine if ART can suppress infection in the iMg, we examined the effects of the antiretroviral drug EFZ, a non-nucleoside reverse transcriptase inhibitor ([@bib9]). EFZ remains a first-line drug in many parts of the world ([@bib39]). Because EFZ blocks HIV reverse transcription, it had an advantage in allowing the study of non-productively infected, HIV-exposed cells alongside productively infected cells, a scenario thought to occur in brains of ART-treated HIV+ people. At day 15, EFZ reduced the infection rate by two-thirds to 29.2% ± 6.3% ([Figures 2](#fig2){ref-type="fig"}A and 2B). Of those iMg infected in the EFZ condition, rates of multinucleation were over 90% and similar to the Inf condition ([Figure 2](#fig2){ref-type="fig"}C), and 100% of P24(−) iMg in the Inf+ EFZ culture were single nucleated ([Figure 2](#fig2){ref-type="fig"}D). Reverse transcriptase activity was severely reduced with EFZ treatment ([Figure 2](#fig2){ref-type="fig"}E). The combined impaired reverse transcriptase and reduced percentage of P24(+) cells shows that EFZ effectively suppressed new infection, allowing us to study both infected and uninfected iMg in the same culture.

Infected iMg Produced Proinflammatory Cytokines at Peak Infection, Which Is Tempered by EFZ Treatment {#sec2.3}
-----------------------------------------------------------------------------------------------------

HIV infection in the CNS leads to changes in cytokine profiles ([@bib13]). Therefore, we quantified the changes in production of relevant cytokines in iMg over the course of infection ± EFZ. Infection led to increased production of several proinflammatory cytokines, specifically IL-1b (p \< 0.01), IL-1a (p \< 0.05), transforming growth factor α (TNF-α) (p \< 0.05), and most prominently, IL-8 (p \< 0.01) ([Figures 2](#fig2){ref-type="fig"}F--2I). However, the two other cytokines tested: IL-6 and IL-10, did not change across any condition ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B). It was expected that the anti-inflammatory IL-10 would not increase, but surprising that IL-6 did not increase ([@bib34]).

Infected iMg cultures exposed to EFZ had less production of IL-1b, IL-8, TNF-α, and IL-1a ([Figures 2](#fig2){ref-type="fig"}F--2I), suggesting a reduced inflammatory reaction, which recapitulates what is seen in ART-treated patients. Uninf, Uninf + EFZ, and the DMSO vehicle control did not elucidate a cytokine reaction across the six cytokines tested ([Figures S2](#mmc1){ref-type="supplementary-material"}C--S2G).

Infected iMg Have Impaired Cell-Cycle Regulation and DNA Repair and Increased Expression of Inflammatory Genes {#sec2.4}
--------------------------------------------------------------------------------------------------------------

To investigative overall gene expression changes during infection, we performed bulk RNA-seq on three iMg lines ± HIV infection, which revealed significant changes in cell-cycle regulation and DNA repair ([Figure S3](#mmc1){ref-type="supplementary-material"}A), consistent with our observation that HIV infection of iMg results in multinucleation. Although no inflammatory pathways were identified by Ingenuity Pathway Analysis, many inflammatory genes involved in the complement system, nuclear factor κB (NF-κB) signaling, and TNF-α signaling were significantly upregulated, as well as *IL1b*, *CCL8*, and *FOS* ([Figure S3](#mmc1){ref-type="supplementary-material"}C).

Collectively, these data show that the iMg exhibit an inflammatory response similar to that seen *in vivo* with increased production of IL-8, IL-1b, IL-1a, and TNF-α. This inflammatory response is strongly attenuated with EFZ. RNA-seq analysis revealed changes in cell cycle and inflammation between uninfected and infected iMg as expected.

Generation of iPSC-Derived Tri-cultures of iNeurons, iAstrocytes, and iMicroglia {#sec2.5}
--------------------------------------------------------------------------------

iNrn were generated by an established protocol that generates a homogeneous population of glutamatergic, forebrain-like excitatory neurons ([@bib42]). iPSC-derived astrocytes (iAst) were generated by brief exposure of iPSCs to the NGN2 transcription factor used to drive iNrn differentiation, and that *in vivo* is expressed by cortical progenitors before their conversion from neurogenesis to gliogenesis. We noticed that, after 2 days of NGN2 production, cells express the neural progenitor markers Nestin and NCAM and the astrocyte marker SOX9 ([@bib19]) ([Figure S4](#mmc1){ref-type="supplementary-material"}A). Because the NGN2 protocol produces a homogeneous population of neurons, we posited that shifting the differentiation at the neural progenitor stage would yield a relatively homogeneous population of iAst. We thus shifted the differentiation to astrocytes by removing the NGN2-inducing agent doxycycline at day 2, while promoting astrocytic differentiation and proliferation with fibroblast growth factor 2 (FGF-2), epidermal growth factor (EGF), and fetal bovine serum (FBS) ([@bib27]). After 70 days the iAst were switched to Sciencell Astrocyte Media ([Figure 3](#fig3){ref-type="fig"}A). After 90 days, RNA-seq revealed similar overall gene expression between iAst and fetal human astrocytes (Hu Ast), including several key astrocyte genes ([Figures 3](#fig3){ref-type="fig"}B and 3F). qRT-PCR validation of *THBS1* confirmed similar expression Hu Ast and iAst ([Figure 3](#fig3){ref-type="fig"}C). We confirmed several of these genes at the protein level, including Nestin, glutamine synthetase, THBS1, an important protein in early synaptogenesis ([@bib5]), and SOX9, revealing a relatively homogeneous population ([Figures 3](#fig3){ref-type="fig"}D and 3E). The iAst exhibited modest glutamate uptake and propagated Ca^2+^ waves in a gap junction-dependent manner, demonstrated by halted Ca^2+^ propagation with 100 μM carbenoxolone, a gap junction blocker ([Figures S4](#mmc1){ref-type="supplementary-material"}F--S4I and [Video S1](#mmc2){ref-type="supplementary-material"}). While in mono-culture, the iAst did not detectably express GFAP, GLT-1, or GLAST ([Figures S4](#mmc1){ref-type="supplementary-material"}B--S4D), in tri-culture, single-cell RNA-seq (scRNA-seq) showed expression of *GLT-1* in iAst ([Figure S4](#mmc1){ref-type="supplementary-material"}E). As neuronal activity regulates GLT-1 in astrocytes ([@bib38]), iAst have a more *in vivo*-like phenotype when in the more physiologically relevant tri-culture.Figure 3Generation and Characterization of iAst and Formation of Tri-cultures(A) Timeline for iAstrocyte differentiation.(B) Bulk RNA-seq normalized read counts of select astrocyte specific genes from primary human astrocytes and iAst. n = 3 cell lines, Benjamini-Hochberg, FDR = 0.01, error bars represent SEM.(C) qRT-PCR validation for expression of *THBS1* in Hu Ast and iAst. Probe normalized to *GAPDH* expression. n = 3 cell lines, two-tailed t test, error bars represent SEM.(D) Immunostaining for the astrocyte-specific markers: Nestin, thrombospondin-1, glutamine synthetase, SOX9, and secondary control. Scale bar represents 50 μm.(E) Percentage of DAPI(+) cells that are double-positive for astrocyte marker. n = 3 cell lines, error bars represent SEM.(F) PCA for monocyte-derived macrophages, iMicroglia, primary human astrocytes, and iAstrocytes, and ([@bib1]) iMg, iPSC, iHPC, and primary human microglia. Each dot represents a bulk RNA-seq sample. MDM, monocyte-derived macrophage; Hum. Ast., primary fetal human astrocytes; iHPC, induced hematopoietic progenitor cells. iPSC, iHPC, Hum. Mg., iMg samples were all retrieved from [@bib1].(G) Flowchart for differentiations into iMg, iAst, and iNrn and combination into tri-culture ± HIV infection and ART.

Video S1. Calcium Wave Propagation, Related to Figure 3

We also exposed the iAst in mono-culture to the most highly expressed cytokines in the HIV-infected iMg, to determine whether the cytokines produced by infected iMg can elicit an inflammatory response in the iAst. We exposed the iAst to IL-1b and IL-8 at 10 ng/mL for 8 h and then analyzed the supernatants on the same six-cytokine panel. We found that, of the six cytokines tested, the iAst produced increased amounts of IL-1a ([Figure S3](#mmc1){ref-type="supplementary-material"}B), suggesting that the iMicroglia can elicit an inflammatory response in the iAst.

We next sought to study iMg in an *in vitro* setting amenable to the study of synaptic phagocytosis and the influences of HIV and ART on gene expression in forebrain cells. To accomplish this we independently generated iNrn, iAst, and iMg cells, and then placed them in mixed cultures. For this study, analysis was performed 14 days after all 3 cell types are combined ([Figure 3](#fig3){ref-type="fig"}G), as our intention was to focus on the acute phase of exposure of forebrain-like neurons, astrocytes, and microglia to productively HIV-infected microglia. Having validated mono-cultures and assembled tri-cultures, we next used scRNA-seq to investigate cell-type-specific gene expression changes during infection ± EFZ.

scRNA-Seq Identified Each of the Three Cell Types in all Four Conditions {#sec2.6}
------------------------------------------------------------------------

To create the tri-culture, we began the iNrn differentiation, added the iAst post-puromycin selection at D5 of the iNrn differentiation, and added the iMg at D7 of the iNrn differentiation, so that the iAst had time to acclimate before addition of HIV-infected iMg. The tri-culture was maintained for an additional 14 days, to D21 of the iNrn differentiation in NBM/B27 with neurotrophin 3 (NT-3) and brain-derived neurotrophic factor (BDNF) as described before ([@bib42]). To assay gene expression changes in each of the three cell types during HIV infection ± EFZ, we conducted scRNA-seq on four conditions: Uninf, Inf, Inf + EFZ, and Uninf + EFZ ([Figure 4](#fig4){ref-type="fig"}A). Cells were sequenced from the Uninf (n = 6,564), Inf (n = 7,431), Inf + EFZ (n = 7,111), and Uninf + EFZ (n = 10,071) conditions, with comparable numbers of each cell type per condition ([Figure S5](#mmc1){ref-type="supplementary-material"}D). All conditions were then aggregated and initially analyzed through the Cellranger pipeline (10× Genomics, v.3.0.1). Secondary analysis was performed using the Seurat package in R. We generated 16 unbiased clusters ([Figure 4](#fig4){ref-type="fig"}B). First, we separated the clusters by cell type, then broke down each cell cluster by condition. We assigned clusters to one of the three cell types by expression of several key genes: iMg by expression of *IBA1*, *PU.1*, and *CD4*; iNrn by expression of *MAP2* and *SYN1*; and iAst by expression of *THBS1* and *SOX9* ([Figures 4](#fig4){ref-type="fig"}C--4E). There were four clusters (clusters 5, 10, 12, and 13) that did not fit into any of the three cell types by expression of the chosen markers ([Figures 4](#fig4){ref-type="fig"}B and 4F). To determine what the fourth cell type might represent, we examined the expression of the top 20 genes in each of the 4 cell types ([Figure 4](#fig4){ref-type="fig"}G). The gene expression pattern of the undesignated cells best matched the iAst, but scRNA-seq did not capture expression of THBS1 or SOX9, suggesting these cells represent less mature versions of the iAst. Hence, they were excluded from further analysis ([Figure S5](#mmc1){ref-type="supplementary-material"}A). We then separated each cell type by condition ([Figure S5](#mmc1){ref-type="supplementary-material"}B). We examined expression of genes related to inflammation and found the largest change in the iMg among the three cell types ([Figure S5](#mmc1){ref-type="supplementary-material"}C).Figure 4scRNA-Seq Identified Each of the Three Cell Types in all Four Conditions(A) Timeline from start of CMP differentiation through tri-culture for the four conditions.(B) t-SNE of unbiased clustering of combined scRNA-seq from all four conditions.(C--E) Expression patterns of cell-type-specific markers for microglia (C), neurons (D), and astrocytes (E).(F) t-SNE clustering by cell type based on cell-type-specific marker expression. One cluster did not align with any of the three cell types by the expression patterns chosen in (C--E).(G) Heatmap of top 20 genes expressed in each cell type

Inflammatory Pathways and EIF2 Signaling Were Dysregulated among all Three Cell Types during Infection, but iMg Were Most Affected {#sec2.7}
----------------------------------------------------------------------------------------------------------------------------------

To understand the gene expression changes among the three cell types during HIV infection ± EFZ, we first compared the Inf condition with Uninf. Several inflammatory pathways were significantly activated in Inf iMg compared with Uninf iMg, including IL-8 and NF-κB signaling. One of the top pathways dysregulated in Inf iMg compared with Uninf was the EIF2 pathway ([Figure 5](#fig5){ref-type="fig"}B). EIF2 signaling is involved in the UPR and, more broadly, the integrated stress response (ISR) ([@bib17]). The EIF2 pathway was not only dysregulated in iMg, but also was consistently increased in the iAst and iNrn ([Figures S6](#mmc1){ref-type="supplementary-material"}A and S6B). However, only iMg had increased expression of *ATF4* mRNA, the transcription factor involved downstream of ISR activation ([@bib25]) in Uninf v Inf ([Figure S5](#mmc1){ref-type="supplementary-material"}C). Previously, we have shown that the ISR, particularly the PERK arm, is activated in neurons and astrocytes from human brain samples with HAND ([@bib2], [@bib23]).Figure 5iMg Activate RhoGDI and CD40 in Response to HIV Infection with EFZ Treatment(A) t-SNE plot of Uninf and Inf conditions.(B) Ingenuity Pathway Analysis of iMg between Uninf and Inf conditions. Uninf is baseline. Benjamini-Hochberg FDR = 0.05, Fisher\'s exact \<0.05, *Z* score cutoff ±0.5.(C) t-SNE plot of Uninf and Inf + EFZ conditions.(D) Ingenuity Pathway Analysis of iMg between Uninf and Inf + EFZ conditions. Uninf is baseline. Benjamini-Hochberg FDR = 0.05, Fisher\'s exact \<0.05, *Z* score cutoff ±0.5.(E) Specific genes dysregulated that are involved in the RhoGDI and CD40 pathways in Inf + EFZ iMg compared with Uninf iMg. Red genes are downregulated. Green genes are upregulated.

Inf + EFZ Caused Distinct Increased Activation of RhoGDI and CD40 Pathways {#sec2.8}
--------------------------------------------------------------------------

We next compared Uninf with Inf + EFZ, expecting to see a dampened immune response compared with Inf. Many of the top affected pathways in Inf iMg were related to inflammation, and there is a stark difference between Inf iMg and Inf + EFZ iMg ([Figures 5](#fig5){ref-type="fig"}B and 5D). However, the Inf + EFZ had a much milder inflammatory reaction, where RhoGDI and CD40 signaling were the only upregulated pathways compared with Uninf iMg ([Figures 5](#fig5){ref-type="fig"}D and 5E). RhoGDI negatively regulates Rac, which functions in multiple inflammation pathways ([@bib41]), and CD40 activates NF-κB signaling ([@bib8]). A milder inflammatory response corroborates well with lesser disease severity seen in HAND patients who are taking ART ([@bib32]). Interestingly, EIF2 signaling was only activated in the iNrn in Inf + EFZ ([Figures 5](#fig5){ref-type="fig"}D, [S6](#mmc1){ref-type="supplementary-material"}C, and S6D).

The scRNA-seq data suggest that the microglia were most affected by the infection ± EFZ, with major changes to EIF2 signaling, inflammatory, oxidative damage, and phagocytic gene pathways. However, the distinct activation of RhoGDI and CD40 in the Inf + EFZ condition suggests that the combination of Inf + EFZ creates a unique effect not seen with infection or EFZ alone.

Inf + EFZ Had an Attenuated, but Distinct Inflammatory Response Compared with Inf {#sec2.9}
---------------------------------------------------------------------------------

Inf iMg had increased activity in several inflammatory pathways, including IL-6 signaling, neuroinflammation signaling, and Fcγ receptor-mediated phagocytosis compared with Inf + EFZ, suggesting that the Inf + EFZ had an overall lower immune response. However, the EIF2 signaling pathway, part of the ISR, was lower in Inf iMg compared with Inf + EFZ ([Figure S6](#mmc1){ref-type="supplementary-material"}E).

Remarkably, EFZ treatment alone created distinct changes in immune-related signaling pathways in the iMg ([Figure S6](#mmc1){ref-type="supplementary-material"}F), creating a unique cassette of dysregulated pathways not fully recapitulated in any other comparison with Uninf. These results show a stark difference in responses to EFZ treatment alone and EFZ treatment with infection, suggesting combinatorial and probably interacting effects of infection and EFZ treatment.

iMg Synaptophagocytosis Is Impaired in Inf, Inf + EFZ iMg, and Uninf + EFZ iMg {#sec2.10}
------------------------------------------------------------------------------

To further explore the differences in iMg responses to infection ± EFZ and EFZ treatment alone, we interrogated the ability of iMg to phagocytose synapses. Fcγ receptor-mediated phagocytosis pathway was activated in the Inf iMg as well as the Uninf + EFZ iMg compared with Uninf iMg ([Figures 5](#fig5){ref-type="fig"}B and [S6](#mmc1){ref-type="supplementary-material"}F). In addition, HIV-infected macrophages and uninfected macrophages exposed to HIV display decreased phagocytic capabilities, specifically through the Fcγ receptor-mediated pathway, due to Nef and Tat inhibiting endocytosis ([@bib10], [@bib26]). However, human microglia synaptophagocytosis in the context of HIV infection has not been tested.

In tri-cultures evaluated 14 days after addition of the iMg, we found colocalization of SYN1 in the LAMP1+ lysosomes of the iMg ([Figures 6](#fig6){ref-type="fig"}A and 6B), suggesting that the iMg phagocytize synaptic material. We confirmed that iMg are in contact with iNrn ([Figure 6](#fig6){ref-type="fig"}C), and importantly, only the iMg are infected as only they, and not the iNrn ([Figure 6](#fig6){ref-type="fig"}D) or iAst, show P24 immunofluorescence. In addition, 1 out of 1,208 iAst in the Inf condition had reads for p24 from the scRNA-seq. These results suggest that it is unlikely that astrocytes are productively infected but may internalize HIV particles from the infected microglia at very low levels. We were also able to delineate infected from uninfected iMg in the Inf + EFZ condition by multinucleation, which is present in nearly all P24 + iMg ([Figures 2](#fig2){ref-type="fig"}A and [S7](#mmc1){ref-type="supplementary-material"}B).Figure 6HIV-Infected iMicroglia Have Reduced Synaptophagocytosis, which Is Ameliorated by EFZ Treatment(A and B) Immunostaining (A) and surface reconstruction of a side view (B) of iMg in an iNrn co-culture displaying synaptic phagocytosis by colocalization of synaptophysin+ (red) puncta within LAMP1+ (blue) lysosomes in IBA1+ (green) iMg. Sale bar represents 10 μm.(C) Giant multinucleated IBA1+ (green) iMg potentially interacting with synaptophysin+ (red) synapses on MAP2+ (yellow) dendrites. Sale bar represents 50 μm.(D) Multinucleated iMg, but not MAP2+ (green) iNrn or iAst, are P24+ (red) in the tri-culture after 14 days. Sale bar represents 50 μm.(E) Representative surface reconstructions of synaptophysin signal (red) within IBA1+ (green) iMg in the Uninf, Uninf + EFZ, and Inf tri-cultures. SN, single nucleated; MN, multinucleated. Scale bar represents 5 μm.(F) Synaptophagy is significantly decreased in infected iMg ± EFZ and uninfected iMg + EFZ compared with control. n = 4 (Uninf = 4, Uninf + EFZ = 4, Inf = 6, Inf + EFZ = 6) independent differentiations of WT6, one-way ANOVA, Dunnett\'s post hoc analysis; ^∗^p \< 0.05; error bars represent SEM.

The Inf iMg phagocytosed 70.9% less synapses than Uninf iMg (p \< 0.01). In addition, in the Inf + EFZ condition, the infected (multinucleated) had 68.2% reduced phagocytosis (p \< 0.01). However, the uninfected (single nucleated) iMg in the Inf + EFZ condition showed trends toward reduction in synaptophagy but was not statistically significant (p = 0.1). Finally, Uninf + EFZ condition iMg phagocytosed 57.1% less than Uninf iMg (p \< 0.05) ([Figures 6](#fig6){ref-type="fig"}E and 6F). Multiple factors from the virus itself, the immune response, and the effects of antiretrovirals are acting on the iMg during HIV infection. All these factors may play a role in reducing synaptic phagocytosis and warrant future study.

To confirm that differences in apparent iMg synaptophagy are not secondary to reduced numbers of synapses overall in a given culture condition, we also measured local and random (50-μm radius areas with no iMg) synapse density to ensure the uninfected microglia were not in a more synapse dense area ([Figures S7](#mmc1){ref-type="supplementary-material"}A and S7C). In fact, there was no significant difference in iMg-proximal or random synapse density across all conditions ([Figures S7](#mmc1){ref-type="supplementary-material"}D and S7E). This finding aligns with previous studies that demonstrate inhibition of phagocytosis by viral proteins Tat and Nef in both infected and uninfected macrophages ([@bib10], [@bib26]) and is also consistent with ART-related impairment of phagocytosis ([@bib14]).

EFZ Reduced the Production of IL-8 and IL-1b by Infected iMg, but Enhanced TNF-α {#sec2.11}
--------------------------------------------------------------------------------

To validate the activation of cytokine and inflammatory pathways in infected microglia ± EFZ, we compared cytokine production between each condition in tri-culture. Starting at the time of iMg addition, we collected supernatant every 5 days until day 14 of tri-culture. Reverse transcriptase activity confirmed that the iMg in the infected condition remain productively infected ([Figure 7](#fig7){ref-type="fig"}A). IL-8 and IL-1b were significantly increased in the infected tri-culture compared with uninfected control 5 days after iMg introduction (p \< 0.0001, p \< 0.001). IL-1b remained increased over uninfected at each time point; however, IL-8 decreases by day 10 ([Figures 7](#fig7){ref-type="fig"}B and 7C). The Inf + EFZ condition had consistent, significant reduced cytokine production of IL-8 from D10 through D14 (p \< 0.0001) and IL-1b at D5 (p \< 0.01) compared with Uninf. Uninf + EFZ had the lowest levels of cytokine production across all the groups ([Figures 7](#fig7){ref-type="fig"}B--7D). In addition, there was no increase in TNF-α in the Inf tri-culture. However, the Inf + EFZ condition did have increased TNF-α compared with all other conditions at D5 ([Figure 7](#fig7){ref-type="fig"}D). The Inf and Inf + EFZ tri-cultures also did not exhibit increases in IL-6 or IL-10, similar to our culture findings ([Figures S2](#mmc1){ref-type="supplementary-material"}H and S2I). These data combined with the scRNA data suggest there are distinct influences on the inflammatory response during infection alone and infection with EFZ. Inf iMg exclusively had increased expression of *CXCL8* and *IL1B* genes ([Figure S5](#mmc1){ref-type="supplementary-material"}C). In addition, IL-8 and NF-κB signaling were activated only in Inf iMg compared with Uninf by scRNA-seq ([Figure 5](#fig5){ref-type="fig"}B) Interestingly, TNF-α regulates *AP-1* (*FOS*) ([@bib7]), a CD40 signaling pathway gene that is upregulated in Inf + EFZ iMg when compared with the Uninf ([Figures S5](#mmc1){ref-type="supplementary-material"}C and 5D). These results further suggest distinct inflammatory reactions from Inf and Inf + EFZ that are observed in the iMg.Figure 7Inf + EFZ Mitigates IL-1b and IL-8 Production, but Increases TNF-α Production(A) Reverse transcriptase activity of Uninf, Inf, and Inf + EFZ tri-culture. n = 3 infections of WT6, one-way ANOVA, Dunnett\'s post hoc analysis; ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001; error bars represent SEM.(B--D) Cytokine analysis of Uninf, Uninf + EFZ, Inf, and Inf + EFZ iMg displays increase in IL-1b (B) and IL-8 (C) production in the Inf tri-culture, and Inf + EFZ had increased TNF-α (D). n = 3 infections of WT6, two-way ANOVA, Tukey\'s post hoc analysis; ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001; error bars represent SEM.

Discussion {#sec3}
==========

We describe an hiPSC tri-culture model to investigate the interdependent and individual roles of microglia, astrocytes, and neurons in the context of HIV infection. In recent years, there have been several new differentiation protocols for these cell types ([@bib1], [@bib31], [@bib42]) and several iPSC/primary cell co-cultures that have studied various neurological disorders ([@bib22], [@bib30]). This model advances previous works in exploring gene expression changes with scRNA-seq in the context of viral infection and relevant drug treatments to begin to unfurl a particularly difficult disease to study.

This model recapitulates several previous *in vivo* findings, such as increases in IL-8 and IL-1b production in microglia and EIF2 signaling in astrocytes and neurons ([@bib2], [@bib13]). The consistent activation of EIF2 signaling in all three cell types not only recapitulates previous findings, but also suggests microglia have dysregulated EIF2 signaling. ISR and EIF2 activation has been implicated in establishing initial viral replication ([@bib18]). A recent study also found stress response genes, including the ISR-associated gene *ATF4*, upregulated in the brains of older HIV-positive patients ([@bib35]). The UPR and consequently EIF2 activation has been implicated in multiple neurodegenerative disorders ([@bib33]), these findings bolster the possibility that UPR and ISR activation play important roles in HAND development or at least the initial response to HIV in the brain.

We also found that the gene pathways associated with IL-8, IL-1b, and TNF-α production were upregulated in iMg, suggesting that the microglia are the main culprit in the initial response to HIV infection. However, iMg infection seems to lead to reduced phagocytosis of synapses. This falls in line with previously reported impaired phagocytosis by HIV-infected or exposed macrophages ([@bib10], [@bib26]). While random synapse density was variable, there was consistent reduced synaptic particles in Inf iMg, suggesting that there was reliably a surplus of synapses. Although not significant, Uninf + EFZ cultures had consistently less overall synapse density, suggesting that the reduced phagocytosis may be due to a global reduction in synapses. In addition, we cannot rule out the possibility that the Inf or Uninf + EFZ were more efficient in degrading the synaptic particles. Ideally, future studies using live-imaging are warranted to resolve this issue. How iMg phagocytosis would be affected or if inflammation patterns would change in longer-term cultures remain to be determined.

In addition, we discovered a starkly different immune response at the gene and functional level in Inf versus Inf + EFZ, characterized by distinct CD40/RhoGDI pathway activation and TNF-α production. CD40 and RhoGDI activation could be controlled by the increased production of TNF-α that was only found in the Inf + EFZ condition. This persistent immune activation highlights the need for further studies into the role that antiretrovirals play in propagating the chronic inflammation seen in HIV patients today ([@bib21]). The mitigated reaction we observed with EFZ treatment is consistent with human studies showing a reduced severity of HAND with the widespread use of antiretroviral therapies ([@bib32]), but also with its persistence despite control of viral load. Furthermore, we revealed a substantial immune response to EFZ treatment alone. This warrants further study, particularly due to the recommended prophylactic use of ART in HIV-negative patients ([@bib36]).

hiPSC cultures are particularly useful for studying HIV neuropathology, since human primary neuronal cells and postmortem tissue are limited in availability and not amenable to molecular manipulation. In addition, HIV only infects human cells, rendering the interpretation of results from animal models more convoluted. Hence, mechanistic studies of the influences of HIV and ART on human neural cells are limited. This tri-culture system allows us to better study the mechanisms of early HIV infection in the brain. However, there are caveats to this system that must be considered. Each of the iPSC-derived cell types are similar to their *in vivo* counterparts by gene and protein expression, as well as function, but are not exact. In addition, the iCells\' gene expression profile at the end stage of differentiation is relatively immature and more closely represents early stages of development *in vivo*. Still, our culture system allows reductionist study of three key cell types over weeks of infection, but it may be refined by inclusion of additional cell types to further optimize modeling HAND in the adult and/or chronic setting.

This tri-culture has validated several findings in the field, as well as, produced multiple findings for HIV neuropathology. However, this model is not restricted to HIV neuropathology and can also be utilized to study other neurological disorders. This highly tractable, reductive system can be genetically and pharmacologically modified at any stage. These differentiations could also be used on patient-derived cells, creating a disease-relevant, patient-specific tri-culture system. Similar cultures have been developed ([@bib16], [@bib30]), but not to this complexity or with a focus on viral infections. The innovation of the tri-culture is not the individual differentiations of iMg or iAst, as there are many published differentiations. Rather, it is an all hiPSC tri-culture that reliably recapitulated the intricate interactions among multiple cell types during HIV infection and revealed new, potential therapeutic targets. Alternatively differentiated iNrn, iMg, or iAst or additional cell types could be implemented. The tri-culture can be another instrumental tool in understanding the workings of complex neurological disorders and in developing novel therapeutic strategies.

Experimental Procedures {#sec4}
=======================

iNeuron Differentiation of iPSCs {#sec4.1}
--------------------------------

iPSCs were transfected with two plasmids VSVG.HIV.SIN.cPPT.CMV.mNgn2.WPRE and VSVG.HIV.SIN.cPPT.CMV.rTTA.WPRE, produced by Marius Wernig (Stanford University) and packaged by the University of Pennsylvania Viral Vector Core. Cells were exposed to 1 μg/mL polybrene (Sigma-Aldrich TR-1003). The medium is fully exchanged 6 h after exposure. iPSCs are differentiated according to a previously published method ([@bib42]). In brief, after transfection, iPSCs were exposed to N2 medium containing 5 mL N2 Supplement-B (STEMCELL Technologies 07156), 0.5 mL 55 mM β-mercaptoethanol (Life Technologies 21985-023), 0.5 mL primocin (Invivogen ant-pm-2), BDNF (10 ng/mL, PeproTech 450-02), NT-3 (10 ng/mL, PeproTech 450-03), laminin (200 ng/mL, Sigma L2020), and doxycycline (2 μg/mL, Sigma D3072) in DMEM/F12 (Gibco 11,320-033) for 24 h (DIV0). Cells were then exposed to puromycin (5 μg/mL, Sigma P9620) for 24 h in the same N2 medium (DIV1). iNeurons were re-plated 24 h later (DIV2) to experiment-appropriate plates coated with Matrigel GFR (Corning 354230) (1:20 DMEM). Cells were washed 2× in PBS and lifted with StemPro accutase (Thermo Fisher Scientific, A11105-01) for 5 min at 37°C. Cells were spun down at 1,000 rpm for 5 min at room temperature. Cells were resuspended and plated in iN medium (Neurobasal-A medium; Invitrogen, A24775-01) with 5 mM glucose (Sigma, G5146), 10 mM sodium pyruvate (Sigma, P5280), glutamax (Life Technologies, 35050-061), penicillin/streptomycin (Thermo Fisher Scientific, 15140-148), BDNF and NT-3 (10 ng/mL), and doxycycline (2 μg/mL) through 9 days. Ara-C (2 μM, Sigma, C6645) was added on DIV3, and there was a full medium exchange 24 h later (DIV4). Doxycycline was discontinued at DIV10 for the rest of the 21-day differentiation.

iAstrocyte Differentiation of iPSCs {#sec4.2}
-----------------------------------

iPSCs transfected with the NGN2 virus were put through the first 2 days of the iNeuron differentiation. On day 3, cells were exposed to astrocyte differentiation medium: N2 medium (without BDNF, NT-3, laminin, and doxycycline), 10% FBS (HyClone SH30071.03HI), B-27 with vitamin A (Thermo Fisher Scientific, 17504044), FGF-2 (20 ng/mL, R&D Systems, 233-FB-025) and EGF (20 ng/mL, R&D Systems, 236-EG-200). After 30 days, EGF was removed and FGF2 reduced to 5 ng/mL. After 70 total days, cells were switched into Astrocyte Medium (Sciencell, 1801). Experiments were performed after 90 total days of differentiation.

iMicroglia Differentiation of iPSCs {#sec4.3}
-----------------------------------

iPSCs were differentiated into CMPs according to the published protocol ([@bib29]) by the Human Pluripotent Stem Cell Core (CHOP). CMPs were plated at 333k cells/well in a 24-well CellBIND plate (Corning 3337). CMPs were differentiated in iMg medium (RPMI 1640 medium, GE Healthcare Life Sciences, SH30027.01) with 10% FBS (HyClone, SH30071.03HI), recombinant human IL-34 (100 ng/mL, R&D Systems, 5265-IL-010), CSF-1 recombinant human protein (25 ng/mL, Thermo Fisher Scientific, PHC9504), and recombinant human TGF-β1 (50 ng/mL, PeproTech, 100-21). Half medium changes were performed every 2 days for 11 days.

Tri-culture Combination {#sec4.4}
-----------------------

iNeurons were differentiated as described above and re-plated on DIV2 to Matrigel (Corning, 354230) coated (1:20 DMEM) Nunc Lab-Tek II 8-well chamber slides (Thermo Fisher Scientific, 62407-296) at 70k cells/well in iN medium. On DIV5 of iNeuron differentiation, the iAstrocytes were added at 50k cells/well. On DIV7 of iNeuron differentiation, iMicroglia were added at 100k cells/well. Cultures were taken out to DIV21 of iNeuron differentiation.

Statistics {#sec4.5}
----------

GraphPad Prism 8 was used for statistical analysis. One-way ANOVA and Dunnett\'s post hoc, two-way ANOVA and Tukey\'s post hoc, two-way ANOVA and Sidak\'s post hoc, two-tailed t test, or two-tailed paired t test were used as indicated. p values are indicated in figures as ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001; n.s., not significant.
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